DNA advancements could transform public health but raise ethical dilemmas
New DNA research offers breakthroughs in early disease detection and personalized treatments, impacting millions. However, it also raises ethical concerns about privacy, consent, and the psychological effects of genetic testing on families and individuals.
| Key Data Point | Details |
|---|---|
| Researcher | Suzanne Onstwedder (RIVM and Amsterdam UMC) |
| Institution | VU University Amsterdam |
| Current Heel Prick Participation | 99% of parents |
| Potential DNA Application | Expansion of heel prick screening to detect more conditions via DNA |
| Commercial DNA Self-Tests | Available outside regular healthcare, raising privacy and interpretation concerns |
| Stakeholders Involved | Researchers, healthcare professionals, policymakers, ethicists, citizens |
The National Institute for Public Health and the Environment (RIVM) plays a crucial role in advising the Dutch government on public health policies, including genetic screening programs like the heel prick test. Their research informs decisions that balance scientific progress with ethical and societal considerations.
Happy with Openrijk?
Then support us with a small contribution
external link to whydonate.comRead the full translated article below
More DNA knowledge offers opportunities for public health but requires careful choices
New knowledge about DNA offers significant opportunities for public health, but also demands careful implementation and broad collaboration. This is evident from the PhD research conducted by Suzanne Onstwedder (RIVM and Amsterdam UMC). Today, she will defend her thesis at VU University Amsterdam.
Researchers are increasingly uncovering the relationship between DNA (deoxyribonucleic acid) and health. This is creating new possibilities for earlier disease detection, improved diagnoses, and treatments better tailored to individual patients.
Complex and sensitive
In her research, Onstwedder emphasizes the importance of carefully weighing potential opportunities and risks. Applying DNA knowledge to improve public health is complex. Genetic information is not only a crucial source of insights into health and disease but also intricate and sensitive. DNA is unique to each individual and contains information about personal traits and health risks. Additionally, family members share part of their DNA. A test on one person may therefore reveal information about relatives—sometimes without their knowledge or consent.
DNA in heel prick screening
Onstwedder cites the heel prick screening for newborns as an example where DNA knowledge could be applied. Currently, nearly all parents (99%) choose to have their baby participate in the heel prick screening. The Dutch government, which provides the screening, is carefully considering major changes to the program. Internationally, research is underway into the possibility of using DNA tests to detect more conditions in the blood collected from newborns. The question remains whether parents want to know about these varied disease risks for their child. It is crucial to strike a balance between fully utilizing the added value of heel prick screening and the potential drawbacks of incorporating DNA tests.
DNA applications beyond regular healthcare
In her thesis, Onstwedder also examined DNA applications outside regular healthcare, such as in the market for commercial DNA self-tests. Citizens can obtain information about their genetic predisposition to health and disease through self-tests, without involving a doctor. While this increases the accessibility of DNA tests, it also raises questions about interpretation, privacy, and may lead to unnecessary anxiety.
Collaboration is key for responsible application
Onstwedder concludes that technological research and progress alone are insufficient to use DNA knowledge wisely for public health. In addition to technical and clinical research, ethical, societal, and legal analyses are essential. It is vital that doctors and researchers carefully consider which genetic information they collect, analyze, and disclose. At the same time, it is important for citizens and patients to be well-informed about the potential consequences of a DNA test. Responsible use of new DNA knowledge therefore requires collaboration among many parties, including researchers, healthcare professionals, policymakers, legal experts, ethicists, citizens, and patients. Only by bringing together different perspectives can it be determined what constitutes responsible use—now and in the future. The findings of this research thus provide valuable input for better alignment between science, policy, and practice.